ArticleMedChemComm2019

Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: potential antitumour dual agents.

Elena González-Hernández et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.